+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Research Antibodies Market Size, Share & Trends Analysis Report By Product (Primary Antibodies), By Type (Monoclonal Antibodies), By Technology, By Source, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 160 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 4538749
The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.76% from 2023 to 2030. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.

An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.

The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.

Research Antibodies Market Report Highlights

  • In 2022, the primary product segment held the largest revenue share due to the higher specificity and direct detection capabilities offered by the antibodies
  • By type, monoclonal antibodies captured a substantial share in 2022 due to the increase in COVID-19-related research activities involving the use of such antibodies
  • The western blotting technology segment held a dominant share of over 29.57% in 2022 because of the increasing investments in R&D activities by several biotechnology and pharmaceutical companies and the rapidly growing applications of antibodies in western blots created for proteomic studies
  • By end-use, academic and research institutions held the largest share of over 61.17% in 2022 due to a rise in funding opportunities and growth in the number of scientific institutions involved in life sciences
  • In 2022, North America accounted for the largest share of over 39.15% due to the widespread presence of life sciences research institutions and numerous biotechnology and biopharmaceutical manufacturers in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Investment In R&D
3.2.1.2. Growing Stem Cells and Neurobiology Research
3.2.1.3. Increase In Research Academies and Industry Collaborations
3.2.1.4. Rise In the Availability of Technologically Advanced Products
3.2.1.5. Rise In Proteomics and Genomics Research
3.2.2. Market Restraint and Challenges Analysis
3.2.2.1. Uncertain Government Regulations
3.2.2.2. Quality Concerns Associated with Research Antibodies and Time- & Cost-Intensive Process Of Antibody Development
3.2.3. Market Opportunities Analysis
3.2.3.1. Growing Demand for Personalized Medicine and Rising Focus on Biomarker Discovery
3.2.3.2. Increasing Opportunities In Various Emerging Markets
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Research Antibodies Market: Product Movement Analysis
4.2. Primary Antibodies
4.2.1. Primary Antibodies Market, 2018 - 2030 (USD Billion)
4.3. Secondary Antibodies
4.3.1. Secondary Antibodies Market, 2018 - 2030 (USD Billion)
Chapter 5. Type Business Analysis
5.1. Research Antibodies Market: Type Movement Analysis
5.2. Monoclonal Antibodies
5.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
5.3. Polyclonal Antibodies
5.3.1. Polyclonal Antibodies Market, 2018 - 2030 (USD Billion)
Chapter 6. Technology Business Analysis
6.1. Research Antibodies Market: Technology Movement Analysis
6.2. Immunohistochemistry
6.2.1. Immunohistochemistry Market, 2018 - 2030 (USD Billion)
6.3. Immunofluorescence
6.3.1. Immunofluorescence Market, 2018 - 2030 (USD Billion)
6.4. Western Blotting
6.4.1. Western Blotting Market, 2018 - 2030 (USD Billion)
6.5. Flow Cytometry
6.5.1. Flow Cytometry Market, 2018 - 2030 (USD Billion)
6.6. Immunoprecipitation
6.6.1. Immunoprecipitation Market, 2018 - 2030 (USD Billion)
6.7. ELISA
6.7.1. ELISA Market, 2018 - 2030 (USD Billion)
6.8. Others
6.8.1. Other Technologies Market, 2018 - 2030 (USD Billion)
Chapter 7. Source Business Analysis
7.1. Research Antibodies Market: Source Movement Analysis
7.2. Mouse
7.2.1. Mouse Market, 2018 - 2030 (USD Billion)
7.3. Rabbit
7.3.1. Rabbit Market, 2018 - 2030 (USD Billion)
7.4. Goat
7.4.1. Goat Market, 2018 - 2030 (USD Billion)
7.5. Others
7.5.1. Other Sources Market, 2018 - 2030 (USD Billion)
Chapter 8. Application Business Analysis
8.1. Research Antibodies Market: Application Movement Analysis
8.2. Infectious Diseases
8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
8.3. Immunology
8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
8.4. Oncology
8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
8.5. Stem Cells
8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
8.6. Neurobiology
8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
8.7. Others
8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)
Chapter 9. End-Use Business Analysis
9.1. Research Antibodies Market: End-use Movement Analysis
9.2. Academic & Research Institutes
9.2.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)
9.3. Contract Research Organizations
9.3.1. Contract Research Organizations Market, 2018 - 2030 (USD Billion)
9.4. Pharmaceutical & Biotechnology Companies
9.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Billion)
Chapter 10. Regional Business Analysis
10.1. Research Antibodies Market Share By Region, 2022 & 2030
10.2. North America
10.2.1. SWOT Analysis
10.2.2. North America Research Antibodies Market, 2018 - 2030 (USD Billion)
10.2.3. U.S.
10.2.3.1. Key Country Dynamics
10.2.3.2. Target Disease Prevalence
10.2.3.3. Competitive Scenario
10.2.3.4. U.S. Research Antibodies Market, 2018 - 2030 (USD Billion)
10.2.4. Canada
10.2.4.1. Key Country Dynamics
10.2.4.2. Target Disease Prevalence
10.2.4.3. Competitive Scenario
10.2.4.4. Canada Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3. Europe
10.3.1. SWOT Analysis
10.3.2. Europe Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.3. UK
10.3.3.1. Key Country Dynamics
10.3.3.2. Target Disease Prevalence
10.3.3.3. Competitive Scenario
10.3.3.4. UK Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.4. Germany
10.3.4.1. Key Country Dynamics
10.3.4.2. Target Disease Prevalence
10.3.4.3. Competitive Scenario
10.3.4.4. Germany Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.5. France
10.3.5.1. Key Country Dynamics
10.3.5.2. Target Disease Prevalence
10.3.5.3. Competitive Scenario
10.3.5.4. France Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.6. Italy
10.3.6.1. Key Country Dynamics
10.3.6.2. Target Disease Prevalence
10.3.6.3. Competitive Scenario
10.3.6.4. Italy Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.7. Spain
10.3.7.1. Key Country Dynamics
10.3.7.2. Target Disease Prevalence
10.3.7.3. Competitive Scenario
10.3.7.4. Spain Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.8. Denmark
10.3.8.1. Key Country Dynamics
10.3.8.2. Target Disease Prevalence
10.3.8.3. Competitive Scenario
10.3.8.4. Denmark Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.9. Sweden
10.3.9.1. Key Country Dynamics
10.3.9.2. Target Disease Prevalence
10.3.9.3. Competitive Scenario
10.3.9.4. Sweden Research Antibodies Market, 2018 - 2030 (USD Billion)
10.3.10. Norway
10.3.10.1. Key Country Dynamics
10.3.10.2. Target Disease Prevalence
10.3.10.3. Competitive Scenario
10.3.10.4. Norway Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4. Asia Pacific
10.4.1. SWOT Analysis
10.4.2. Asia Pacific Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.3. Japan
10.4.3.1. Key Country Dynamics
10.4.3.2. Target Disease Prevalence
10.4.3.3. Competitive Scenario
10.4.3.4. Japan Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.4. China
10.4.4.1. Key Country Dynamics
10.4.4.2. Target Disease Prevalence
10.4.4.3. Competitive Scenario
10.4.4.4. China Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.5. India
10.4.5.1. Key Country Dynamics
10.4.5.2. Target Disease Prevalence
10.4.5.3. Competitive Scenario
10.4.5.4. India Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.6. Australia
10.4.6.1. Key Country Dynamics
10.4.6.2. Target Disease Prevalence
10.4.6.3. Competitive Scenario
10.4.6.4. Australia Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.7. Thailand
10.4.7.1. Key Country Dynamics
10.4.7.2. Target Disease Prevalence
10.4.7.3. Competitive Scenario
10.4.7.4. Thailand Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.8. South Korea
10.4.8.1. Key Country Dynamics
10.4.8.2. Target Disease Prevalence
10.4.8.3. Competitive Scenario
10.4.8.4. South Korea Research Antibodies Market, 2018 - 2030 (USD Billion)
10.4.9. Singapore
10.4.9.1. Key Country Dynamics
10.4.9.2. Target Disease Prevalence
10.4.9.3. Competitive Scenario
10.4.9.4. Singapore Research Antibodies Market, 2018 - 2030 (USD Billion)
10.5. Latin America
10.5.1. SWOT Analysis
10.5.2. Latin America Research Antibodies Market, 2018 - 2030 (USD Billion)
10.5.3. Brazil
10.5.3.1. Key Country Dynamics
10.5.3.2. Target Disease Prevalence
10.5.3.3. Competitive Scenario
10.5.3.4. Brazil Research Antibodies Market, 2018 - 2030 (USD Billion)
10.5.4. Mexico
10.5.4.1. Key Country Dynamics
10.5.4.2. Target Disease Prevalence
10.5.4.3. Competitive Scenario
10.5.4.4. Mexico Research Antibodies Market, 2018 - 2030 (USD Billion)
10.5.5. Argentina
10.5.5.1. Key Country Dynamics
10.5.5.2. Target Disease Prevalence
10.5.5.3. Competitive Scenario
10.5.5.4. Argentina Research Antibodies Market, 2018 - 2030 (USD Billion)
10.6. MEA
10.6.1. SWOT Analysis
10.6.2. MEA Research Antibodies Market, 2018 - 2030 (USD Billion)
10.6.3. South Africa
10.6.3.1. Key Country Dynamics
10.6.3.2. Target Disease Prevalence
10.6.3.3. Competitive Scenario
10.6.3.4. South Africa Research Antibodies Market, 2018 - 2030 (USD Billion)
10.6.4. Saudi Arabia
10.6.4.1. Key Country Dynamics
10.6.4.2. Target Disease Prevalence
10.6.4.3. Competitive Scenario
10.6.4.4. Saudi Arabia Research Antibodies Market, 2018 - 2030 (USD Billion)
10.6.5. UAE
10.6.5.1. Key Country Dynamics
10.6.5.2. Target Disease Prevalence
10.6.5.3. Competitive Scenario
10.6.5.4. UAE Research Antibodies Market, 2018 - 2030 (USD Billion)
10.6.6. Kuwait
10.6.6.1. Key Country Dynamics
10.6.6.2. Target Disease Prevalence
10.6.6.3. Competitive Scenario
10.6.6.4. Kuwait Research Antibodies Market, 2018 - 2030 (USD Billion)
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Share Analysis, 2022
11.4. Company Profiles/Listing
11.4.1. Abcam Plc
11.4.1.1. Overview
11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. Merck KGaA
11.4.2.1. Overview
11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.2.3. Product Benchmarking
11.4.2.4. Strategic Initiatives
11.4.3. Thermo Fisher Scientific, Inc.
11.4.3.1. Overview
11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.3.3. Product Benchmarking
11.4.3.4. Strategic Initiatives
11.4.4. Cell Signaling Technology, Inc.
11.4.4.1. Overview
11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.4.3. Product Benchmarking
11.4.4.4. Strategic Initiatives
11.4.5. Santa Cruz Biotechnology Inc.
11.4.5.1. Overview
11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.5.3. Product Benchmarking
11.4.5.4. Strategic Initiatives
11.4.6. PerkinElmer, Inc.
11.4.6.1. Overview
11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.6.3. Product Benchmarking
11.4.6.4. Strategic Initiatives
11.4.7. Becton, Dickinson and Company
11.4.7.1. Overview
11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.7.3. Product Benchmarking
11.4.7.4. Strategic Initiatives
11.4.8. Bio-Techne Corporation
11.4.8.1. Overview
11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.8.3. Product Benchmarking
11.4.8.4. Strategic Initiatives
11.4.9. Proteintech Group, Inc.
11.4.9.1. Overview
11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.9.3. Product Benchmarking
11.4.9.4. Strategic Initiatives
11.4.10. Jackson ImmunoResearch Inc
11.4.10.1. Overview
11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.10.3. Product Benchmarking
11.4.10.4. Strategic Initiative
List of Tables
Table 1 List of abbreviations
Table 2 Global research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 3 Global research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 4 Global research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 5 Global research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 6 Global research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 7 Global research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 8 Global research antibodies market, by region, 2018 - 2030 (USD Billion)
Table 9 North America research antibodies market, by country, 2018 - 2030 (USD Billion)
Table 10 North America research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 11 North America research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 12 North America research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 13 North America research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 14 North America research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 15 North America research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 16 U.S. research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 17 U.S. research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 18 U.S. research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 19 U.S. research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 20 U.S. research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 21 U.S. research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 22 Canada research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 23 Canada research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 24 Canada research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 25 Canada research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 26 Canada research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 27 Canada research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 28 Europe research antibodies market, by country, 2018 - 2030 (USD Billion)
Table 29 Europe research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 30 Europe research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 31 Europe research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 32 Europe research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 33 Europe research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 34 Europe research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 35 UK research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 36 UK research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 37 UK research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 38 UK research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 39 UK research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 40 UK research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 41 Germany research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 42 Germany research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 43 Germany research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 44 Germany research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 45 Germany research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 46 Germany research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 47 France research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 48 France research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 49 France research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 50 France research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 51 France research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 52 France research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 53 Italy research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 54 Italy research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 55 Italy research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 56 Italy research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 57 Italy research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 58 Italy research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Spain research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 60 Spain research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 61 Spain research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 62 Spain research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 63 Spain research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 64 Spain research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 65 Denmark research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 66 Denmark research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 67 Denmark research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 68 Denmark research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 69 Denmark research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 70 Denmark research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 71 Sweden research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 72 Sweden research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 73 Sweden research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 74 Sweden research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 75 Sweden research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 76 Sweden research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 77 Norway research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 78 Norway research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 79 Norway research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 80 Norway research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 81 Norway research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 82 Norway research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 83 Asia Pacific research antibodies market, by country, 2018 - 2030 (USD Billion)
Table 84 Asia Pacific research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 85 Asia Pacific research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 86 Asia Pacific research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 87 Asia Pacific research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 88 Asia Pacific research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 89 Asia Pacific research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 90 Japan research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 91 Japan research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 92 Japan research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 93 Japan research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 94 Japan research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 95 Japan research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 96 China research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 97 China research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 98 China research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 99 China research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 100 China research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 101 China research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 102 India research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 103 India research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 104 India research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 105 India research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 106 India research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 107 India research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 108 South Korea research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 109 South Korea research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 110 South Korea research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 111 South Korea research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 112 South Korea research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 113 South Korea research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 114 Thailand research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 115 Thailand research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 116 Thailand research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 117 Thailand research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 118 Thailand research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 119 Thailand research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 120 Australia research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 121 Australia research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 122 Australia research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 123 Australia research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 124 Australia research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 125 Australia research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 126 Singapore research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 127 Singapore research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 128 Singapore research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 129 Singapore research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 130 Singapore research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 131 Singapore research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 132 Latin America research antibodies market, by country, 2018 - 2030 (USD Billion)
Table 133 Latin America research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 134 Latin America research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 135 Latin America research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 136 Latin America research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 137 Latin America research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 138 Latin America research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 139 Brazil research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 140 Brazil research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 141 Brazil research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 142 Brazil research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 143 Brazil research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 144 Brazil research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 145 Mexico research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 146 Mexico research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 147 Mexico research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 148 Mexico research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 149 Mexico research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 150 Mexico research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 151 Argentina research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 152 Argentina research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 153 Argentina research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 154 Argentina research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 155 Argentina research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 156 Argentina research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 157 MEA research antibodies market, by country, 2018 - 2030 (USD Billion)
Table 158 MEA research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 159 MEA research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 160 MEA research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 161 MEA research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 162 MEA research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 163 MEA research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 164 South Africa research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 165 South Africa research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 166 South Africa research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 167 South Africa research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 168 South Africa research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 169 South Africa research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 170 Saudi Arabia research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 171 Saudi Arabia research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 172 Saudi Arabia research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 173 Saudi Arabia research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 174 Saudi Arabia research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 175 Saudi Arabia research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 176 UAE research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 177 UAE research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 178 UAE research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 179 UAE research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 180 UAE research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 181 UAE research antibodies market, by end-use, 2018 - 2030 (USD Billion)
Table 182 Kuwait research antibodies market, by product, 2018 - 2030 (USD Billion)
Table 183 Kuwait research antibodies market, by type, 2018 - 2030 (USD Billion)
Table 184 Kuwait research antibodies market, by technology, 2018 - 2030 (USD Billion)
Table 185 Kuwait research antibodies market, by source, 2018 - 2030 (USD Billion)
Table 186 Kuwait research antibodies market, by application, 2018 - 2030 (USD Billion)
Table 187 Kuwait research antibodies market, by end-use, 2018 - 2030 (USD Billion)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Research antibodies market segmentation
Figure 8 Market snapshot, 2022
Figure 9 Market trends & outlook
Figure 10 Market driver relevance analysis (current & future impact)
Figure 11 Market restraint relevance analysis (current & future impact)
Figure 12 PESTEL analysis
Figure 13 Porter’s five forces analysis
Figure 14 Global research antibodies market: Product movement analysis
Figure 15 Global research antibodies market, for primary antibodies, 2018 - 2030 (USD Billion)
Figure 16 Global research antibodies market, for secondary antibodies, 2018 - 2030 (USD Billion)
Figure 17 Global research antibodies market: Type movement analysis
Figure 18 Global research antibodies market, for monoclonal antibodies, 2018 - 2030 (USD Billion)
Figure 19 Global research antibodies market, for polyclonal antibodies, 2018 - 2030 (USD Billion)
Figure 20 Global research antibodies market: Technology movement analysis
Figure 21 Global research antibodies market, for immunohistochemistry, 2018 - 2030 (USD Billion)
Figure 22 Global research antibodies market, for immunofluorescence, 2018 - 2030 (USD Billion)
Figure 23 Global research antibodies market, for western blotting, 2018 - 2030 (USD Billion)
Figure 24 Global research antibodies market, for flow cytometry, 2018 - 2030 (USD Billion)
Figure 25 Global research antibodies market: immunoprecipitation, movement analysis
Figure 26 Global research antibodies market, for ELISA, 2018 - 2030 (USD Billion)
Figure 27 Global research antibodies market, for other technologies, 2018 - 2030 (USD Billion)
Figure 28 Global research antibodies market: Source movement analysis
Figure 29 Global research antibodies market, for mouse, 2018 - 2030 (USD Billion)
Figure 30 Global research antibodies market, for rabbit, 2018 - 2030 (USD Billion)
Figure 31 Global research antibodies market, for goat, 2018 - 2030 (USD Billion)
Figure 32 Global research antibodies market, for other sources, 2018 - 2030 (USD Billion)
Figure 33 Global research antibodies market: Application movement analysis
Figure 34 Global research antibodies market, for infectious diseases, 2018 - 2030 (USD Billion)
Figure 35 Global research antibodies market, for immunology, 2018 - 2030 (USD Billion)
Figure 36 Global research antibodies market, for oncology, 2018 - 2030 (USD Billion)
Figure 37 Global research antibodies market, for stem cells, 2018 - 2030 (USD Billion)
Figure 38 Global research antibodies market, for neurobiology, 2018 - 2030 (USD Billion)
Figure 39 Global research antibodies market, for other applications, 2018 - 2030 (USD Billion)
Figure 40 Global research antibodies market: End-use movement analysis
Figure 41 Global research antibodies market, for academic & research institutes, 2018 - 2030 (USD Billion)
Figure 42 Global research antibodies market, for contract research organizations, 2018 - 2030 (USD Billion)
Figure 43 Global research antibodies market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Billion)
Figure 44 Regional marketplace: key takeaways
Figure 45 Regional outlook, 2022 & 2030
Figure 46 Global research antibodies market: region movement analysis
Figure 47 North America research antibodies market, 2018 - 2030 (USD Billion)
Figure 48 U.S. research antibodies market, 2018 - 2030 (USD Billion)
Figure 49 Canada research antibodies market, 2018 - 2030 (USD Billion)
Figure 50 Europe research antibodies market, 2018 - 2030 (USD Billion)
Figure 51 Germany research antibodies market, 2018 - 2030 (USD Billion)
Figure 52 UK research antibodies market, 2018 - 2030 (USD Billion)
Figure 53 France research antibodies market, 2018 - 2030 (USD Billion)
Figure 54 Italy research antibodies market, 2018 - 2030 (USD Billion)
Figure 55 Spain research antibodies market, 2018 - 2030 (USD Billion)
Figure 56 Denmark research antibodies market, 2018 - 2030 (USD Billion)
Figure 57 Sweden research antibodies market, 2018 - 2030 (USD Billion)
Figure 58 Norway research antibodies market, 2018 - 2030 (USD Billion)
Figure 59 Asia Pacific research antibodies market, 2018 - 2030 (USD Billion)
Figure 60 Japan research antibodies market, 2018 - 2030 (USD Billion)
Figure 61 China research antibodies market, 2018 - 2030 (USD Billion)
Figure 62 India research antibodies market, 2018 - 2030 (USD Billion)
Figure 63 Australia research antibodies market, 2018 - 2030 (USD Billion)
Figure 64 Thailand research antibodies market, 2018 - 2030 (USD Billion)
Figure 65 South Korea research antibodies market, 2018 - 2030 (USD Billion)
Figure 66 Singapore research antibodies market, 2018 - 2030 (USD Billion)
Figure 67 Latin America research antibodies market, 2018 - 2030 (USD Billion)
Figure 68 Brazil research antibodies market, 2018 - 2030 (USD Billion)
Figure 69 Mexico research antibodies market, 2018 - 2030 (USD Billion)
Figure 70 Argentina research antibodies market, 2018 - 2030 (USD Billion)
Figure 71 MEA research antibodies market, 2018 - 2030 (USD Billion)
Figure 72 South Africa research antibodies market, 2018 - 2030 (USD Billion)
Figure 73 Saudi Arabia research antibodies market, 2018 - 2030 (USD Billion)
Figure 74 UAE research antibodies market, 2018 - 2030 (USD Billion)
Figure 75 Kuwait research antibodies market, 2018 - 2030 (USD Billion)

Companies Mentioned

  • Abcam Plc
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Cell Signaling Technology, Inc.
  • Santa Cruz Biotechnology Inc.
  • PerkinElmer, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Proteintech Group, Inc.
  • Jackson ImmunoResearch Inc

Methodology

Loading
LOADING...

Table Information